{"slug":"biogen","name":"바이오젠","name_en":"Biogen","ticker":"BIIB","updated_at":"2026-07-11T10:15:19.062+00:00","canonical":"https://valuechain.wiki/biogen","kicker":"헬스케어 · S&P 500","kicker_en":"Health Care · S&P 500","lead":"다발성경화증과 알츠하이머 등 신경질환 치료제를 개발하는 바이오 제약사다. S&P 500 구성종목. 섹터: 헬스케어(Biotechnology). 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A biopharmaceutical company developing treatments for multiple sclerosis, Alzheimer's, and other neurological diseases. S&P 500 constituent. Sector: Health Care (Biotechnology). Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"다발성경화증"},{"name":"알츠하이머·신약"},{"name":"바이오시밀러"}],"total":"약 $9.7B (FY2024)"},"segments_en":{"parts":[{"name":"Multiple Sclerosis"},{"name":"Alzheimer's & New Products"},{"name":"Biosimilars"}],"total":"~$9.7B (FY2024)"},"returns_yearly":{"2021":-2,"2022":15.4,"2023":-6.6,"2024":-40.9,"2025":15.1,"2026":13.2},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}